Westshore Wealth’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-2,330
Closed -$203K 102
2024
Q1
$203K Buy
+2,330
New +$199K 0.08% 98
2023
Q3
Sell
-2,649
Closed -$233K 106
2023
Q2
$233K Sell
2,649
-68
-3% -$5.85K 0.12% 91
2023
Q1
$219K Buy
2,717
+136
+5% +$11.1K 0.12% 97
2022
Q4
$201K Buy
2,581
+100
+4% +$8.11K 0.11% 101
2022
Q3
$200K Hold
2,481
0.14% 89
2022
Q2
$223K Buy
2,481
+462
+23% +$46.8K 0.15% 84
2022
Q1
$224K Buy
+2,019
New +$213K 0.15% 85
2021
Q3
Sell
-2,079
Closed -$258K 117
2021
Q2
$258K Buy
2,079
+16
+0.8% +$2.01K 0.13% 112
2021
Q1
$244K Buy
+2,063
New +$242K 0.14% 115
2019
Q4
$564K Buy
+4,970
New +$545K 0.62% 29

Other funds holding MDT

Westshore Wealth's MDT Position: Q2 2024 in Review

Westshore Wealth sold out of Medtronic (MDT) in Q2 2024, closing a stake of 2,330 shares — an estimated $203K sold.

Westshore Wealth first reported a position in MDT in Q4 2019 and held it in 10 quarters. The position peaked at $564K in Q4 2019. 2,029 funds tracked by Wall St. Rank hold MDT as of Q2 2024.

  • Westshore Wealth reported no remaining Medtronic position as of Q2 2024 after selling out during the quarter.
  • Westshore Wealth sold 2,330 Medtronic shares in Q2 2024, an estimated $203K.
  • Westshore Wealth first reported a position in Medtronic in Q4 2019 and held it in 10 quarters.
  • Westshore Wealth's Medtronic position peaked at $564K in Q4 2019.
  • 2,029 funds tracked by Wall St. Rank held Medtronic as of Q2 2024.

Based on Westshore Wealth's 13F filing for Q2 2024, filed 1 Nov 2024.